Background: Immunotherapy has recently become a hot topic in the field of oncology, with PD-L1 playing a crucial role in this area. However, the research on PD-L1 correlation prediction models is not fully understood. The aim of our study was to investigate the role of PD-L1-related genes in lung adenocarcinoma immunity.Methods: The mRNA and clinical data were obtained from the Cancer Genome Atlas database. DESeq2, Glmnet, forestplot, clusterProfiler and enrichplot were used to analyze the mRNA and clinical data. Western blotting and real-time qRT-PCR were used to confirm the GPR115, MF12, GREB1L, SPRR1B and LIPK mRNA and protein expression.Results: Firstly, 562 cases of TCGA lung adenocarcinoma, including 503 of tumor tissue and 59 of normal tissue were collected. The dataset was analyzed using the DESeq2 package of R. 1,251 high- and 285 low-expression genes were obtained. The tumor samples were divided into CD274-high and CD274-low expression samples and 873 genes were up-regulated and 1,010 genes were down regulated between CD274-high and CD274-low samples. Subsequently, the intersection of 1,251 and 873 was taken to obtain 110 genes that were both highly expressed genes in tumors and CD274 high-expression samples. Survival analysis of 110 genes yielded 5 meaningful genes including GPR115, MF12, GREB1L, SPRR1B, and LIPK (p < 0.001). These five genes were used to construct PD-L1 risk predictors. Cytokine-cytokine receptor interaction and IL-17 signaling pathway were involved in the regulation of this risk model factors to lung adenocarcinoma. The level of effector memory CD4 T cells and Type 2 T helper cells were correlated with the risk model factor. Importantly, the PD-L1 risk prediction model could effectively predict the prognosis of patients.Conclusion: The construction of PD-L1 risk model was of great significance for the treatment of lung adenocarcinoma.
Background: NUP155 was reported to involve breast invasive carcinoma and hepatocellular carcinoma. We hypothesized that NUP155 and NDC1impacted the progression of NSCLC.Methods: The dataset was analyzed to find differentially expressed genes. Functional enrichment analysis and Kaplan-Meier survival analysis were performed for differentially expressed genes. Western blot, Clone formation assay, Transwell assay and CCK-8 assay were performed to determine the performance and role of the target gene in NSCLC.Results: The research found that the NUP family played a role in various diseases. Differential expression analysis and survival analysis were performed to identify 6 related-genes, including NUP155, NDC1, KPNA2, MAD2L1, NUP62CL, and POM121L2NUP155 and NDC1 could interact with NUP53, respectively. This effect was necessary to complete the assembly of the nuclear pore complex.Conclusion: NUP155 interacted with NDC1 to complete the assembly of the nuclear pore complex, which promoted the development of NSCLC. Our study demonstrated that NUP155 was expected to be a potential target for the treatment of NSCLC.
Objective: To evaluate and compare the clinical value of computed tomography (CT) and magnetic resonance imaging (MRI) in the preoperative TNM staging of esophageal carcinoma.Methods: A total of 1,209 patients with histologically confirmed esophageal cancer who underwent preoperative CT (n = 868) or MRI (n = 341) scanning from January 2014 to December 2024 were retrospectively analyzed. Tumor location, histologic type, and postoperative pathological TNM stage were recorded. CT and MRI findings were compared with pathological results as the standard.Results: For T-stage, the overall accuracy of CT was 86%, with a sensitivity and specificity of 53 and 89%, respectively. MRI achieved an accuracy of 82%, with sensitivity and specificity of 57 and 93%, respectively. For N-stage, CT showed a sensitivity, specificity, and accuracy of 85, 83, and 84% for mediastinal lymph nodes, and 87, 82, and 83% for abdominal lymph nodes. There was no significant difference in the total accuracy rate of TN staging diagnosis of esophageal cancer between the two groups.Conclusion: Both CT and MRI demonstrate high diagnostic value in the preoperative TNM stage of esophageal carcinoma. While CT is more economic and easier to operate, MRI offers superior contrast of connective tissues and multiplanar imaging, making it particularly valuable in evaluating T4 stage and assessing tumor invasion of adjacent organs. Limitations exist in early T-stage and N-stage assessments due to difficulty distinguishing mucosal infiltration and differentiating metastatic from non-metastatic lymphadenopathy. Multimodal imaging strategies and tumor-targeted contrast agents may enhance staging precision.
30 October 2025 in Current Research in Microbial Sciences
Continuous propagation of Luoyang mung bean sour (LMBS) was employed to simulate industrial production, establishing a stable microbial ecosystem within 18 days that mimicked the characteristics of mature LMBS. To investigate the mechanisms of LMBS formation, the changes and correlations between metabolic profiles and the bacterial community were analyzed during continuous propagation. Through high-throughput sequencing, this study revealed that Lactobacillus became the dominant genus, accounting for 85 % of the bacterial community, and overwhelmed other genera, such as Leuconostoc (0.20 %), Lactococcus (1.19 %), and Acetobacter (8.01 %) after 9 days. Metabolomics analysis identified a total of 2379 differential metabolites. The top 30 metabolites comprised peptides (γ-glutamyl-S-methylcysteine, γ-Glu-Leu), organic acids (indoleacrylic acid, tricarballylic acid), and flavonoids (vitexin, isovitexin). The relative abundance of peptides and flavonoids increased at post-fermentation, including Gly-Tyr-His, Arg-Ile-His, and apigenin. Metabolic pathway analysis indicated that protein degradation and amino acid metabolism were the primary pathways, with a focus on tryptophan metabolism and arginine biosynthesis. Key metabolites-organic acids, peptides, flavonoids, antibiotics, and carbohydrates-also exhibited strong correlations with dominant genera (|r| > 0.7). By elucidating potential regulatory relationships between dominant genera and metabolites, this study provides a foundation for future LMBS industrialization.
Background: Lung adenocarcinoma (LUAD) frequently harbors activating mutations in the epidermal growth factor receptor (EGFR), making EGFR tyrosine kinase inhibitors (EGFR-TKIs) a critical component of targeted therapy. Although third-generation EGFR-TKIs, such as Furmonertinib, have improved outcomes for patients with EGFR-mutant LUAD, drug resistance and tumor adaptation remain major challenges. The cellular and molecular mechanisms underlying response and adaptation to Furmonertinib, particularly within the tumor microenvironment (TME), are not fully understood. Methods: We performed single-cell RNA sequencing on tumor and paired paracancerous tissues from EGFR-positive LUAD patients before and after Furmonertinib treatment, integrating both public and in-house datasets. We systematically analyzed changes in cellular composition, gene expression profiles, pathway enrichment, and ligand–receptor-mediated cell–cell communication. Results: Furmonertinib treatment led to a marked reduction in tumor cell proportion and profound remodeling of the TME. There was an increase in T cell infiltration, particularly CD4 + T cells, and a decrease in exhausted CD8 + T cells, indicating a shift toward a less immunosuppressive microenvironment. Cancer-associated fibroblasts and monocytes were also enriched post-treatment. Tumor cells exhibited increased EGFR expression, along with transcriptomic reprogramming characterized by upregulation of signaling, immune, and differentiation pathways, and downregulation of metabolic and protein synthesis genes. Cell–cell communication analysis revealed attenuation of immunosuppressive signaling (such as MIF axis) and enhancement of alternative ligand–receptor interactions, including LAMC1- and EGFR-related pathways. Conclusions: Our integrative single-cell analysis reveals that Furmonertinib therapy induces significant cellular and molecular changes in EGFR-positive LUAD, including TME remodeling, transcriptomic adaptation, and reprogramming of intercellular communication networks. These findings provide insight into the mechanisms of Furmonertinib response and resistance, and may inform strategies to optimize EGFR-TKI therapy.